Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
9.19
+0.12 (1.32%)
Feb 21, 2025, 4:00 PM EST - Market closed
Amicus Therapeutics Employees
Amicus Therapeutics had 517 employees as of December 31, 2023. The number of employees increased by 33 or 6.82% compared to the previous year.
Employees
517
Change (1Y)
33
Growth (1Y)
6.82%
Revenue / Employee
$1,021,847
Profits / Employee
-$108,522
Market Cap
2.76B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
FOLD News
- 2 days ago - Amicus Therapeutics, Inc. (FOLD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates - GlobeNewsWire
- 4 days ago - Kuehn Law Encourages Investors of Amicus Therapeutics, Inc. to Contact Law Firm - GlobeNewsWire
- 12 days ago - Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025 - GlobeNewsWire
- 19 days ago - Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025 - GlobeNewsWire
- 4 weeks ago - NCLA Amicus Brief Asks Fifth Circuit to Uphold Jury-Trial Rights in FDIC Enforcement Cases - GlobeNewsWire
- 5 weeks ago - NCLA Amicus Brief Asks Supreme Court to Keep Unlawful Corporate Transparency Act Enjoined - GlobeNewsWire
- 5 weeks ago - 3 Oversold Biotech Names - Seeking Alpha